Table 3

Changes in hemodynamic, anthropometric parameters and BP medications in hypertensive patients over 12 months (propensity matched data)

ParameterPreoperative1 month3 month6 month12 monthMean differenceP valueBetween-group difference at 12 months (mean difference (95% CI))P value for difference in means between groups at 12 months
SBP (mm Hg)RYGB133.4 (16)124.9 (16)127.4 (15.8)125.1 (19.1)124.5 (17.1)8.9 (3)0.003−4.6 (−9.5 to 0.3)0.07
SG132.2 (18.3)124.2 (16.5)127.3 (15.3)123.0 (15.7)129.1 (15.1)3.1 (3.2)0.34
DBP (mm Hg)RYGB80.2 (11.4)74.9 (11.6)76.7 (11.1)76.3 (10.8)72.5 (8.4)7.7 (1.9)<0.001−4.2 (−7.1 to −1.3)0.01
SG80.4 (12.3)76.2 (10.4)76.5 (9.1)74.2 (10.9)76.7 (10.5)3.7 (2.2)0.08
HR (beats/min)RYGB81.4 (13.4)76.3 (12)73.5 (11.1)70.6 (11.2)73.1 (12.1)8.2 (2.4)0.0012.4 (−1.2 to 6)0.2
SG80.3 (12.9)77.2 (14.3)71.5 (13.8)69 (11.9)70.7 (11.4)9.6 (2.3)<0.001
Weight (kg)RYGB134.2 (36.5)121.5 (34.6)110.4 (33.4)99.1 (31)86.7 (24.9)47.5 (6)<0.001−2.3 (−9.3 to 4.7)0.5
SG130.7 (30.3)117.2 (26.1)109 (27.2)100.5 (25.7)89.0 (21.3)41.7 (5.1)<0.001
BMI (kg/m2)RYGB47.5 (10.6)43 (10.1)39.1 (10.4)35.1 (9)30.7 (7)16.8 (1.7)<0.001−0.9 (−2.9 to 1.1)0.4
SG46.8 (9.1)41.8 (7.8)39.1 (8.0)35.8 (7.6)31.6 (6.1)15.2 (1.5)<0.001
BP medsRYGB1.5 (1.4)0.8 (1.1)0.6 (1)0.7 (1.1)0.5 (0.9)0.9 (0.2)<0.001NA1
SG1.6 (1.3)0.6 (0.8)0.7 (0.9)0.5 (0.8)0.5 (0.8)1 (0.2)<0.001
  • Mean difference: mean change within subjects from baseline (presurgery) to follow-up (12 months).

  • P value for baseline to 12 months of follow-up mean difference (two-tailed).

  • Continuous variables described as absolute means (SD). Mean difference reported with SE in parentheses.

  • BMI, body mass index; BP, blood pressure; DBP, diastolic blood pressure; HR, heart rate; NA, not applicable; RYGB, Roux-en-Y gastric bypass; SBP, systolic blood pressure; SG, sleeve gastrectomy.